Cargando…
Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease
BACKGROUND: Non-typhoidal Salmonella are one of the key etiological agents of diarrhoeal disease. The appearance of multiple drug resistance along with resistance to quinolones in this bacterium poses a serious therapeutic problem. We determined the prevalence of nalidixic acid and ciprofloxacin res...
Autores principales: | Panhotra, B.R., Saxena, A.K., Al-Arabi Al-Ghamdi, Ali M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148155/ https://www.ncbi.nlm.nih.gov/pubmed/15573842 http://dx.doi.org/10.5144/0256-4947.2004.332 |
Ejemplares similares
-
Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease
por: Panhotra, B.R., et al.
Publicado: (2004) -
Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi
por: Kadhiravan, Tamilarasu, et al.
Publicado: (2005) -
Evaluation of the current trend of nalidixic acid susceptibility in typhoidal Salmonellae; a marker of therapeutic failure for the fluoroquinolones
por: Abbasi, S, et al.
Publicado: (2011) -
Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to Ciprofloxacin: a case report from Cameroon
por: Nkemngu, Njinkeng J, et al.
Publicado: (2005) -
Characterizing Shigella species distribution and antimicrobial susceptibility to ciprofloxacin and nalidixic acid in Latin America between 2000–2015
por: Sati, Hatim F., et al.
Publicado: (2019)